Vitronectin (Human Recombinant)

Vitronectin (Human Recombinant)_x000D_ Catalog number: B2010568_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 500 ug_x000D_ Molecular Weight or Concentration: 78 kDa_x000D_ Supplied as: Solution_x000D_ Applications: molecular in the study of various cellular systems as well as cell adhesion assays_x000D_ Storage: -20C_x000D_ Keywords: Vitronectin_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Shin K, Lechtenberg BC, Fujimoto LM, Yao Y, Bartra SS, Plano GV, Marassi FM._x000D_ Structure of human Vitronectin C-terminal domain and interaction with_x000D_ Yersinia pestis outer membrane protein Ail. Sci Adv. 2019 Sep_x000D_ 11;5(9):eaax5068._x000D_ _x000D_ 2: Schvartz I, Seger D, Shaltiel S. Vitronectin. Int J Biochem Cell Biol. 1999_x000D_ May;31(5):539-44._x000D_ _x000D_ 3: Shin K, Kent JE, Singh C, Fujimoto LM, Yu J, Tian Y, Im W, Marassi FM._x000D_ Calcium and hydroxyapatite binding site of human vitronectin provides insights_x000D_ to abnormal deposit formation. Proc Natl Acad Sci U S A. 2020 Aug_x000D_ 4;117(31):18504-18510._x000D_ _x000D_ 4: Dugdale B, Kato M, Deo P, Plan M, Harrison M, Lloyd R, Walsh T, Harding R,_x000D_ Dale J. Production of human vitronectin in Nicotiana benthamiana using the_x000D_ INPACT hyperexpression platform. Plant Biotechnol J. 2018 Feb;16(2):394-403._x000D_ _x000D_ 5: Bera A, Subramanian M, Karaian J, Eklund M, Radhakrishnan S, Gana N, Rothwell_x000D_ S, Pollard H, Hu H, Shriver CD, Srivastava M. Functional role of vitronectin in_x000D_ breast cancer. PLoS One. 2020 Nov 19;15(11):e0242141._x000D_ _x000D_ 6: Aaboe M, Offersen BV, Christensen A, Andreasen PA. Vitronectin_ in human_x000D_ breast carcinomas. Biochim Biophys Acta. 2003 May 20;1638(1):72-82._x000D_ _x000D_ 7: Burgos-Panadero R, Noguera I, Cañete A, Navarro S, Noguera R. Vitronectin as_x000D_ a molecular player of the tumor microenvironment in neuroblastoma. BMC Cancer._x000D_ 2019 May 22;19(1):479._x000D_ _x000D_ 8: Chen LH , Sung TC , Lee HH , Higuchi A , Su HC , Lin KJ , Huang YR , Ling QD_x000D_ , Kumar SS , Alarfaj AA , Munusamy MA , Nasu M , Chen DC , Hsu ST , Chang Y ,_x000D_ Lee KF , Wang HC , Umezawa A . Xeno-free and feeder-free culture and_x000D_ differentiation of human embryonic stem cells on recombinant vitronectin-grafted_x000D_ hydrogels. Biomater Sci. 2019 Sep 24;7(10):4345-4362._x000D_ _x000D_ 9: Hintner H, Breathnach SM, Dahlbäck K, Dahlbäck B, Fritsch P. Vitronektin in_x000D_ normaler und läsionaler menschlicher Haut [Vitronectin in normal human skin and_x000D_ in skin lesions]. Hautarzt. 1991 Jan;42(1):16-22._x000D_ 10: Preissner KT, Reuning U. Vitronectin in vascular context: facets of a_x000D_ multitalented matricellular protein. Semin Thromb Hemost. 2011 Jun;37(4):408-24._x000D_ _x000D_ Products Related to Vitronectin (Human Recombinant): Proteins

9000-83-3

Catalog Number: B2010568 (500 ug)

0.15

2

0.5